RSSFDA panel again nixes Avastin for breast cancer
From: The Washington Times | June 29, 2011
A panel of cancer experts has ruled for a second time that Avastin, the best-selling cancer drug in the world, should no longer be used in breast cancer patients, clearing the way for the government to remove its endorsement from the drug.
The unprecedented vote Wednesday by the Food and ...
Filed Under The Wire
Content posted by users from other sites is posted for commentary and news purposes under fair use and each author is responsible for their own postings and a particular posting should not be construed as being endorsed by this site or its owner.
Please Note: The comments section is for both the registered users of this web site as well as non-registered users. All wishing to post comments must comply with our Commenting Rules or risk having their comments stricken. Comments do not necessarily reflect the views of the ownership of this site and should not be taken as such just because they are visible and posted here.
Leave a Reply
Loading ...Recommended Reading:
